Gene · 442908
Papers1,421
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,421
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Curcumin in pancreatic cancer: A comprehensive review of anticancer mechanisms, EMT modulation, and clinical challenges. | Cancer Treat Res Commun | 2026 | 42667846 | PubTator, text mining | PubMed |
| Structural remodeling of tumor microtubes in IDH1 mutation shapes microRNA transfer in glioma. | Neurobiol Dis | 2026 | 42349563 | PubTator, text mining | PubMed |
| Extracellular vesicle cargo dynamics in the bone marrow microenvironment: from hematopoietic homeostasis to malignant transformation. | Extracell Vesicle | 2026 | 42344609 | PubTator, text mining | PubMed |
| Identification of potential key genes and molecular mechanisms of oral squamous cell carcinoma based on integrated bioinformatics approach. | J Genet Eng Biotechnol | 2026 | 41839689 | PubTator, text mining | PubMed |
| X chromosome-encoded microRNAs in immune regulation: sex differences and clinical implications. | Front Glob Womens Health | 2026 | 41799158 | PubTator, text mining | PubMed |
| Investigation of miRNAs affecting schwann cells in patients with trigeminal neuralgia. | Mol Biol Rep | 2026 | 41779213 | PubTator, text mining | PubMed |
| RNA-Based Biomarkers for Diagnostic Discrimination of Ischemic and Hemorrhagic Stroke: A Systematic Review. | J Clin Med | 2026 | 41753079 | PubTator, text mining | PubMed |
| miR-340 improves the efficiency of p53 gene therapy in metastatic prostate cancer cells through downregulation of MDM2. | Sci Rep | 2026 | 41644649 | PubTator, text mining | PubMed |
| Retraction Note: miR-340-FHL2 axis inhibits cell growth and metastasis in ovarian cancer. | Cell Death Dis | 2026 | 41644519 | PubTator, text mining | PubMed |
| Anisomycin Induces Senescence and Death of Ovarian Cancer Stem Cells Through the MicroRNA-340/SENP6/SUMOylation Pathway. | J Gene Med | 2026 | 41494663 | PubTator, text mining | PubMed |
| A Multi-Ancestry GWAS Meta-Analysis Integrated with In-Depth Silico, Systems Biology, and Pharmacogenomics Approaches on Alzheimer's Disease Among 1,198,689 Subjects. | J Mol Neurosci | 2025 | 41329263 | PubTator, text mining | PubMed |
| miR-340 reverses chemotherapy resistance in colon cancer via the PDCD4/WNT/β-catenin signalling pathway. | Sci Rep | 2025 | 41022995 | PubTator, text mining | PubMed |
| Natural protection against oxidative stress in human skin melanocytes. | Commun Biol | 2025 | 40858814 | PubTator, text mining | PubMed |
| Exploring the Link Between the Gut Microbiota and Epigenetic Factors in Anorexia Nervosa. | Brain Behav | 2025 | 40842134 | PubTator, text mining | PubMed |
| Determination of miRNA in tear extracellular vesicles significantly associated with treatment-requiring retinopathy of prematurity: a pilot study. | Sci Rep | 2025 | 40835875 | PubTator, text mining | PubMed |
| miR-27a-3p, miR-222-3p and miR-340-5p as indicators of the antioxidant response activation in gestational diabetes. | Mol Biol Rep | 2025 | 40591006 | PubTator, text mining | PubMed |
| Integrated Analysis of Slow Transit Constipation and Colorectal Cancer Reveals the Co-Pathogenic Targets and Their Potential Clinical Value. | Cancer Invest | 2025 | 40454893 | PubTator, text mining | PubMed |
| Diagnostic accuracy of plasma microRNA as a potential biomarker for detection of endometriosis. | Syst Biol Reprod Med | 2025 | 40053518 | PubTator, text mining | PubMed |
| Circulating extracellular vesicles as potential biomarkers and mediators of acute respiratory distress syndrome in sepsis. | Sci Rep | 2025 | 39953195 | PubTator, text mining | PubMed |
| miR-449a/miR-340 reprogram cell identity and metabolism in fusion-negative rhabdomyosarcoma. | Cell Rep | 2025 | 39799567 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/442908/papers